Tissue Engineering

In a clinical trial in Poland, three dialysis patients had allogenic tissue-engineered vascular grafts implanted to perform as shunts.  The recent report of this work claimed no immunological rejection and that the lab-cultured blood vessels, originating from skin cells, performed better than natural or synthetic materials. Cytograft Tissue Engineering, Inc. (Novato, CA) grew these vessels and the following site details how they did it.  MORE TO SEE INCLUDING SLIDE SHOW AND/OR WEBINAR

Image Credit:  Cytograft Tissue Engineering, Inc